Effect of sex and estrogen therapy on the aging brain: A voxel-based morphometry study

Menopause

Volumn 17, Issue 4, 2010, Pages 846-851

  Lord, Catherine ^a   Engert, Veronika ^b   Lupien, Sonia J ^c   Pruessner, Jens C ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Estrogen; Hippocampus; Hormone therapy; Parietal cortex; Striatum; Voxel based morphometry

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL;

ADULT; AGED; AGING; ANGULAR GYRUS; ARTICLE; BRAIN; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; ESTROGEN THERAPY; FEMALE; FRONTAL LOBE; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRECUNEUS; PREFRONTAL CORTEX; SEX DIFFERENCE; SUBICULUM; TEMPORAL CORTEX; TREATMENT DURATION; VOXEL BASED MORPHOMETRY; COMPARATIVE STUDY; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE;

AGED; BRAIN; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTMENOPAUSE; SEX FACTORS;

EID: 77954927282     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181e06b83     Document Type: Article

References (62)

1. Gur RC, Turetsky BI, Matsui M, et al. Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive per-formance. J Neurosci 1999;19:4065-4072.
2. Murphy DG, DeCarli C, McIntosh AR, et al. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 1996;53:585-594.
3. Xu J, Kobayashi S, Yamaguchi S, Iijima K, Okada K, Yamashita K. Gender effects on age-related changes in brain structure. AJNR Am J Neuroradiol 2000;21:112-118.
4. Coffey CE, Lucke JF, Saxton JA, et al. Sex differences in brain aging: a quantitative magnetic resonance imaging study [erratum appears in Arch Neurol 1998;55:627]. Arch Neurol 1998;55:169-179.
5. Pruessner JC, Collins DL, Pruessner M, Evans AC. Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood. J Neurosci 2001;21:194-200.
6. Raz N, Gunning-Dixon F, Head D, Rodrigue KM, Williamson A, Acker JD. Aging, sexual dimorphism, and hemispheric asymmetry of the cere-bral cortex: replicability of regional differences in volume. Neurobiol Aging 2004;25:377-396.
7. Goldstein JM, Seidman LJ, Horton NJ, et al. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imag-ing. Cereb Cortex 2001;11:490-497.
8. Cowell PE, Turetsky BI, Gur RC, Grossman RI, Shtasel DL, Gur RE. Sex differences in aging of the human frontal and temporal lobes. J Neurosci 1994;14:4748-4755.
9. Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Markesbery WR. Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol Aging 2007;28:1075-1087.
10. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci 2003;23:3295-3301.
11. Lemaitre H, Crivello F, Grassiot B, Alperovitch A, Tzourio C, Mazoyer B. Age-and sex-related effects on the neuroanatomy of healthy elderly. NeuroImage 2005;26:900-911.
12. Fjell AM, Westlye LT, Amlien I, et al. Minute effects of sex on the aging brain: a multisample magnetic resonance imaging study of healthy aging and Alzheimer's disease. J Neurosci 2009;29:8774-8783.
13. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM Incidence Research Group. Neurology 1999;53:1992-1997.
14. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 2002;5:98-102.
15. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997;278:419-424.
16. Stefanick ML. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Am J Med 2005;118:64-73.
17. Coker LH, Espeland MA, Rapp SR, et al. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol 2010;118:304-310.
18. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Post-menopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005;76:103-105.
19. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement ther-apy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288:2123-2129.
20. Fillit HM. The role of hormone replacement therapy in the prevention of Alzheimer disease. Arch Intern Med 2002;162:1934-1942.
21. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in post-menopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-695.
22. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
23. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alz-heimer's disease in women. Am J Epidemiol 1994;140:256-261.
24. Eberling JL, Wu C, Haan MN, Mungas D, Buonocore M, Jagust WJ. Preliminary evidence that estrogen protects against age-related hippo-campal atrophy. Neurobiol Aging 2003;24:725-732.
25. Robertson D, Craig M, van Amelsvoort T, et al. Effects of estrogen therapy on age-related differences in gray matter concentration. Climac-teric 2009;12:301-309.
26. Raz N, Rodrigue KM, Kennedy KM, Acker JD. Hormone replacement therapy and age-related brain shrinkage: regional effects. Neuroreport 2004;15:2531-2534.
27. Erickson KI, Colcombe SJ, Elavsky S, et al. Interactive effects of fitness and hormone treatment on brain health in postmenopausal women. Neurobiol Aging 2007;28:179-185.
28. Erickson KI, Colcombe SJ, Raz N, et al. Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol Aging 2005;26:1205-1213.
29. Ghidoni R, Boccardi M, Benussi L, et al. Effects of estrogens on cogni-tion and brain morphology: involvement of the cerebellum. Maturitas 2006;54:222-228.
30. Boccardi M, Ghidoni R, Govoni S, et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a voxel-based morphometry study. Menopause 2006;13:584-591.
31. Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hor-mone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 2009;72:135-142.
32. Erickson KI, Voss MW, Prakash RS, Chaddock L, Kramer AF. A cross-sectional study of hormone treatment and hippocampal volume in post-menopausal women: evidence for a limited window of opportunity. Neuropsychology 2010;24:68-76.
33. Lord C, Buss C, Lupien SJ, Pruessner JC. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging 2008;29:95-101.
34. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
35. Lord C, Duchesne A, Pruessner JC, Lupien SJ. Measuring indices of lifelong estrogen exposure: self-report reliability. Climacteric 2009;12:387-394.
36. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for auto-matic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998;17:87-97.
37. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994;18:192-205.
38. Zijdenbos AP, Forghani R, Evans AC. Automatic quantification of MS lesions in 3D MRI brain data sets: validation of INSECT. In: Wells WM, Colchester ACF, Delp S, eds. Medical Image Computing and Computer-Assisted Interventation: Proceedings of the MICCAI '98, First Interna-tional Conference, Cambridge, MA, 11-13 October 1998. Vol 1496. Berlin: Springer, 1998:439-448.
39. Worsley KJ, Marret S, Neelin P, Vandal AC, Frisotn KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996;4:58-73.
40. Espeland MA, Tindle HA, Bushnell CA, et al. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci 2009;64:1243-1250.
41. Zec RF, Trivedi MA. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev 2002;12:65-109.
42. Dickerson BC, Sperling RA. Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuro-imaging. Behav Neurol 2009;21:63-75.
43. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alz-heimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asympto-matic amyloid-positive individuals. Cereb Cortex 2009;19:497-510.
44. Lerch JP, Pruessner J, Zijdenbos AP, et al. Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. Neurobiol Aging 2008;29:23-30.
45. Hirao K, Ohnishi T, Hirata Y, et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. NeuroImage 2005;28:1014-1021.
46. McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res 2002;57:357-384.
47. Resnick SM, Maki PM. Effects of hormone replacement therapy on cognitive and brain aging. Ann N Y Acad Sci 2001;949:203-214.
48. Maki PM, Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. NeuroImage 2001;14:789-801.
49. Frey BN, Lord C, Soares CN. Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Meno-pause Int 2008;14:123-128.
50. Soares CN. Menopausal transition and depression: who is at risk and how to treat it? Expert Rev Neurother 2007;7:1285-1293.
51. Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Post-menopausal estrogen use affects risk for Parkinson disease. Arch Neurol 2004;61:886-888.
52. Popat RA, Van Den Eeden SK, Tanner CM, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson dis-ease. Neurology 2005;65:383-390.
53. Simon KC, Chen H, Gao X, Schwarzschild MA, Ascherio A. Repro-ductive factors, exogenous estrogen use, and risk of Parkinson's disease. Mov Disord 2009;24:1359-1365.
54. Bourque M, Dluzen DE, Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol 2009;30: 142-157.
55. Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997;48:S27-S35.
56. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002;3:433-442.
57. Toran-Allerand CD. Estrogen and the brain: beyond ER-α and ER-A. Exp Gerontol 2004;39:1579-1586.
58. Scharfman HE, MacLusky NJ. Estrogen and brain-derived neuro-trophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol 2006;27:415-435.
59. Petanceska SS, Nagy V, Frail D, Gandy S. Ovariectomy and 17A-estradiol modulate the levels of Alzheimer's amyloid A peptides in brain. Neurology 2000;54:2212-2217.
60. Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 2000;21:373-383.
61. Greene RA. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int J Fertil Womens Med 2000;45:253-257.
62. Eberling JL, Reed BR, Coleman JE, Jagust WJ. Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology 2000;55:875-877.